3-day Systemic Antibiotics with Subgingival Instrumentation good enough for aggressive Periodontitis

Written By :  Dr.Niharika Harsha B
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2022-07-10 16:18 GMT   |   Update On 2022-07-10 16:18 GMT
Advertisement

Recent research found that in aggressive periodontitis patients a 3-day systemic administration of Amoxicillin and Metronidazole along with subgingival instrumentation yielded good clinical outcomes after 6 months with fewer adverse events. The study was published in "Journal of Clinical Periodontology."

Periodontitis can cause severe functional and esthetic dysfunctions. It is a multifactorial disease caused due to disturbances in angiogenesis, microbiota, and inflammatory infiltrate. Instrumentation and antibiotics are the mainstays of treatment of periodontitis. Raluca et al conducted a study to evaluate the clinical non-inferiority of a 3-day-protocol of systemic antibiotics (SAB) adjunctive to subgingival instrumentation (SI) compared to a 7-day-protocol in patients with stage III/IV grade C periodontitis.

Advertisement

A randomized study was performed on 50 systemically healthy patients aged 32.7±4.3 years with aggressive periodontitis (stage III/IV grade C periodontitis). Subgingival Instrumentation along with adjunctive antibiotics (AB) like amoxicillin and metronidazole were given. Patients were assigned to two groups of 25 each randomly. Group A was given 500mg antibiotics 3-times-daily for 3 days, followed by a placebo 3-times-daily for 4 days, and group B was given 500mg antibiotics 3-times-daily for 7 days. Clinical, microbial, and immunological parameters were assessed at baseline, 3 and 6 months, and patient-related outcomes after 2 weeks. The number of residual sites with PD≥6mm at 6 months was the primary outcome variable.

Results:

  • For the primary outcome variable, the null hypothesis was rejected and demonstrated the non-inferiority of the 3d AB protocol compared to 7d AB.
  • Comparable clinical improvements were obtained for all parameters with both antibiotic protocols (p>0.05).
  • Significant reduction of all investigated periodontopathogens and pro-inflammatory host-derived markers were observed, without differences between the treatments (p>0.05). 

Thus, researchers concluded that in patients with aggressive periodontitis (stage III/IV grade C periodontitis), the clinical outcomes of a 3-day administration of systemic amoxicillin and metronidazole adjunctive to SI were non-inferior to a 7-day-protocol after 6-months.  

To read the full article, click here:  https://doi.org/10.1111/jcpe.13676 

Cosgarea R, Jepsen S, Heumann C, et al. Clinical, microbiological and immunological effects of 3- or 7-day systemic antibiotics adjunctive to subgingival instrumentation in patients with aggressive (stage III/IV grade C) periodontitis: a randomized placebo-controlled clinical trial [published online ahead of print, 2022 Jul 4]. J Clin Periodontol. 2022;10.1111/jcpe.13676.

Tags:    
Article Source : Journal of Clinical Periodontology

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News